Alix Ventures

www.alix.vc

VCMatch tracks Alix Ventures as an investor focused on Biotech, Digital Health, and AI/ML companies and Pre-Seed and Seed rounds. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Pre-Seed, Seed, Series A

Focus Areas

Biotech, Digital Health, AI/ML

Geography

Not specified

Investment Thesis

Alix Ventures invests at the intersection of technology and biology, backing early-stage Life Science startups that ‘engineer[] biology to drive radical advances in human health.’ They emphasize using ‘capital and networks to help build transformative companies’ and focus on partnering closely with accomplished founders to ‘significantly impact the quality and effectiveness of patient care.’ The firm frames its approach as community- and founder-oriented, combining technical rigor, industry insight, and hands-on support to accelerate TechBio companies.

Is Alix Ventures right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Alix Ventures is most relevant for founders raising Pre-Seed, Seed, and Series A rounds in Biotech, Digital Health, AI/ML, and Medtech.

Focus statement

Alix focuses on early-stage 'TechBio' opportunities — platform companies and infrastructure across 'Novel Applications (Therapeutics/Diagnostics)' and 'Bio-Economy Infrastructure (Services/Manufacturing)', with particular interest in computational bio, synthetic biology, cell & gene therapy, and delivery/diagnostics.

Value Add

Operates a content and community platform (BIOS) to unify the Life Science ecosystem: 'BIOS - Content & community platform' including BIOS Medium, Podcast, Daily Newsletter, BIOS Angels, and BIOS Commons.
Founder-centric, proactive support model — founders praise their 'disciplined approach to pushing support to me instead of waiting for me to pull.'
Deep technical and industry expertise across team and advisors (e.g., practitioners with biotech R&D and startup-building experience such as Brian Fiske and Chas Pulido).
Focus on TechBio intersection (technology + biology) rather than pure digital health or traditional biotech alone — repeatedly emphasizes 'TechBio' and the 'intersection' as a theme.
Network and deal support that materially helps fundraising and industry introductions (founder testimonial: helped 'secure our oversubscribed $52M Series A' and provided 'countless intros to follow on VCs, Pharma KOLs, industry experts, & more').